Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/19440740

Download in:

View as

General Info

PMID
19440740